Saitz TR, Serefoglu EC. The epidemiology of premature ejaculation. Transl Androl Urol. 2016;5:409–15.

Article  Google Scholar 

Serefoglu EC, McMahon CG, Waldinger MD, Althof SE, Shindel A, Adaikan G, et al. An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second international society for sexual medicine ad hoc committee for the definition of premature ejaculation. Sex Med. 2014;2:41–59.

Article  Google Scholar 

Shindel AW, Althof SE, Carrier S, Chou R, McMahon CG, Mulhall JP, et al. Disorders of ejaculation: an AUA/SMSNA guideline. J Urol. 2022;207:504–12.

Article  Google Scholar 

Salonia A, Bettocchi C, Boeri L, Capogrosso P, Carvalho J, Cilesiz NC, et al. European association of urology guidelines on sexual and reproductive health—2021 update: male sexual dysfunction. Eur Urol. 2021;80:333–57.

Article  Google Scholar 

Eassa BI, El-Shazly MA. Safety and efficacy of tramadol hydrochloride on treatment of premature ejaculation. Asian J Androl. 2013;15:138–42.

CAS  Article  Google Scholar 

Rosen RC, Althof S. Impact of premature ejaculation: the psychological, quality of life, and sexual relationship consequences. J Sex Med. 2008;5:1296–307.

Article  Google Scholar 

Rowland DL. Psychological impact of premature ejaculation and barriers to its recognition and treatment. Curr Med Res Opin. 2011;27:1509–18.

Article  Google Scholar 

D’Souza RS, Lang M, Eldrige JS. Prescription Drug Monitoring Program. StatPearls. Treasure Island (FL): StatPearls Publishing; 2021.

Google Scholar 

Rutkow L, Chang HY, Daubresse M, Webster DW, Stuart EA, Alexander GC. Effect of Florida’s prescription drug monitoring program and pill mill laws on opioid prescribing and use. JAMA Intern Med. 2015;175:1642–9.

Article  Google Scholar 

Henry SG, Shev AB, Crow D, Stewart SL, Wintemute GJ, Fenlon C, et al. Impacts of prescription drug monitoring program policy changes and county opioid safety coalitions on prescribing and overdose outcomes in California, 2015-2018. Prev Med. 2021;153:106861.

Article  Google Scholar 

Jern P, Johansson A, Piha J, Westberg L, Santtila P. Antidepressant treatment of premature ejaculation: discontinuation rates and prevalence of side effects for dapoxetine and paroxetine in a naturalistic setting. Int J Impot Res. 2015;27:75–80.

CAS  Article  Google Scholar 

Salonia A, Rocchini L, Sacca A, Pellucchi F, Ferrari M, Carro UD, et al. Acceptance of and discontinuation rate from paroxetine treatment in patients with lifelong premature ejaculation. J Sex Med. 2009;6:2868–77.

CAS  Article  Google Scholar 

Luján S, García-Fadrique G, Morales G, Morera J, Broseta E, Jiménez-Cruz JF. Are urology residents ready to treat premature ejaculation after their training? J Sex Med. 2012;9:404–10.

Article  Google Scholar 

Saleh R, Majzoub A, Abu El-Hamd M. An update on the treatment of premature ejaculation: a systematic review. Arab J Urol. 2021;19:281–302.

Article  Google Scholar 

Fulton-Kehoe D, Lofy KH, Le V, Sterling R, Sears JM, Franklin G. Opioid-prescribing metrics in Washington State: trends and challenges. J Public Health Manag Pr. 2020;26:214–21.

Article  Google Scholar 

Breeden MA, Jacobs CK, Witthaus M, Salas J, Everard KM, Penton E, et al. Prescribing patterns and use of risk-reduction tools after implementing an opioid-prescribing protocol. J Am Board Fam Med. 2020;33:27–33.

Article  Google Scholar 

Champagne-Langabeer T, Madu R, Giri S, Stotts AL, Langabeer JR. Opioid prescribing patterns and overdose deaths in Texas. Subst Abus. 2021;42:161–7.

Article  Google Scholar 

Wu T, Yue X, Duan X, Luo D, Cheng Y, Tian Y, et al. Efficacy and safety of tramadol for premature ejaculation: a systematic review and meta-analysis. Urology. 2012;80:618–24.

Article  Google Scholar 

Sharma AP, Sharma G, Tyagi S, Devana SK, Mavuduru RS, Bora GS, et al. Safety and efficacy of “on-demand” tramadol in patients with premature ejaculation: an updated meta-analysis. Int Braz J Urol. 2021;47:921–34.

Article  Google Scholar